Who's In The Room:
Welcome to the 7th Dermatology Drug Development Summit for Inflammatory Skin Diseases
The Dermatology Drug Development Summit returns for its 7th year as the largest industry focused summit dedicated to advancing treatment options across Atopic Dermatitis, Alopecia Areata, Hidradenitis suppurativa, Prurigo Nodularis and Vitiligo to name a few.
From improving the safety profile of JAK inhibitors to opening the doors to maintenance therapies and cracking the first approved therapies in rare dermatological diseases, these strategic and progressive conversations are not ones to be missed.
This summit provides optimal opportunity to meet with 120+ key opinion leaders from LEO Pharma, AbbVie, Janssen, Sanofi, Almirall, GSK, BMS, Incyte, Dermavant and more to accelerate dermatology pipelines and work towards achieving durable therapies following the success in attaining remittive therapy in Psoriasis.
World-Class Speaker Faculty Includes:
Senior Vice President, Clinical Pharmacology and Experimental Medicine
Vice President, Immunodermatology
Vice President & Head of Global Medical Immunology
This Year's Presenting Companies Include:
Testimonials from the Dermatology Drug Development Summit
“High quality conference providing insights on the opportunities and challenges in dermatology drug development”
“I was able to get something out of each presentation. It was a total success in my opinion.”
Proud to Partner With:
Lead and Hosting Partner